Sitagliptin and Exercise tolerance decreased - a phase IV clinical study of FDA data

Summary:

Exercise tolerance decreased is reported as a side effect among people who take Sitagliptin (sitagliptin), especially for people who are female, 60+ old, also take Amlodipine, and have High blood pressure.

The phase IV clinical study analyzes which people have Exercise tolerance decreased when taking Sitagliptin. It is created by eHealthMe based on reports of 3,929 people who have side effects when taking Sitagliptin from the FDA, and is updated regularly.

What is Sitagliptin?

Sitagliptin has active ingredients of sitagliptin. eHealthMe is studying from 3,933 Sitagliptin users. Check the latest studies of Sitagliptin.

What is Exercise tolerance decreased?

Exercise tolerance decreased is found to be associated with 625 drugs and 723 conditions by eHealthMe. Check the latest studies of Exercise tolerance decreased.

On Jul, 11, 2026

3,929 people reported to have side effects when taking Sitagliptin.
Among them, 26 people (0.66%) have Exercise tolerance decreased.

Could Sitagliptin cause Exercise tolerance decreased?

Among these 26 people:

What is the gender of people who have Exercise tolerance decreased when taking Sitagliptin? *

female: 100 %
male: 0.0 %

What is the age of people who have Exercise tolerance decreased when taking Sitagliptin? *

What are other drugs people take besides Sitagliptin? *

What are other side effects people have besides Exercise tolerance decreased? *

Oedema Peripheral (superficial swelling): 26 people, 100.00%
Mobility Decreased (ability to move is reduced): 26 people, 100.00%
Memory Loss: 26 people, 100.00%
High Blood Pressure: 26 people, 100.00%
Head Injury: 26 people, 100.00%
Drug Ineffective: 26 people, 100.00%
Diabetes Mellitus Inadequate Control: 26 people, 100.00%
Depressed Mood: 26 people, 100.00%
Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving): 26 people, 100.00%
Blood Pressure Abnormal: 26 people, 100.00%

What are the existing conditions these people have? *

Diabetes: 26 people, 100.00%
Restless Leg Syndrome (a powerful urge to move your legs): 26 people, 100.00%
Psoriasis (immune-mediated disease that affects the skin): 26 people, 100.00%
Pain: 26 people, 100.00%
Osteoporosis (bones weak and more likely to break): 26 people, 100.00%
Oedema Peripheral (superficial swelling): 26 people, 100.00%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 26 people, 100.00%
Indigestion: 26 people, 100.00%
High Blood Pressure: 26 people, 100.00%
Wheezing (a high-pitched whistling sound made while you breath): 25 people, 96.15%

* Approximation only. Some reports may have incomplete information.

Do you take Sitagliptin and have Exercise tolerance decreased?

- Check whether Exercise tolerance decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sitagliptin:

Sitagliptin (3,933 reports)

Browse all side effects of Sitagliptin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Exercise tolerance decreased:

Exercise tolerance decreased (625 drugs)

Browse all the conditions that are associated with Exercise tolerance decreased:

Exercise tolerance decreased (723 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sitagliptin (the active ingredients of Sitagliptin) and Sitagliptin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.